Danaher Co. (NYSE:DHR) Stock Position Decreased by Capital Advisors Inc. OK

Capital Advisors Inc. OK lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 3.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 205,865 shares of the conglomerate’s stock after selling 7,504 shares during the quarter. Capital Advisors Inc. OK’s holdings in Danaher were worth $47,256,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher during the 4th quarter valued at about $31,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher during the 4th quarter valued at about $31,000. Finally, Pineridge Advisors LLC boosted its stake in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 1.2 %

Shares of NYSE:DHR opened at $201.15 on Wednesday. The stock has a market capitalization of $145.29 billion, a price-to-earnings ratio of 38.10, a PEG ratio of 2.68 and a beta of 0.83. Danaher Co. has a 1-year low of $199.75 and a 1-year high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a 50 day moving average price of $231.96 and a 200 day moving average price of $251.14.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 earnings per share. On average, research analysts anticipate that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.54%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on DHR shares. Stifel Nicolaus boosted their target price on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Royal Bank of Canada reissued an “outperform” rating and set a $277.00 target price (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Scotiabank started coverage on shares of Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 target price for the company. Stephens reissued an “overweight” rating and set a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Finally, Barclays reduced their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is currently owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.